key: cord-0820875-poeqfp3v
authors: Kamin Mukaz, Debora; Gergi, Mansour; Koh, Insu; Zakai, Neil A.; Judd, Suzanne E.; Sholzberg, Michelle; Baumann Kreuziger, Lisa; Freeman, Kalev; Colovos, Christos; Olson, Nels C.; Cushman, Mary
title: Thrombo‐inflammatory biomarkers and D‐dimer in a biracial cohort study
date: 2021-12-07
journal: Res Pract Thromb Haemost
DOI: 10.1002/rth2.12632
sha: 770bb70d58fb386202b6d9f35efb23094314f0bb
doc_id: 820875
cord_uid: poeqfp3v

BACKGROUND: Higher D‐dimer is a risk factor for cardiovascular diseases and venous thromboembolism. In the general population, D‐dimer and other thrombo‐inflammatory biomarkers are higher among Black individuals, who also have higher risk of these conditions compared to White people. OBJECTIVE: To assess whether Black individuals have an exaggerated correlation between D‐dimer and thrombo‐inflammatory biomarkers characteristic of cardiovascular diseases. METHODS: Linear regression was used to assess correlations of 11 thrombo‐inflammatory biomarkers with D‐dimer in a cross‐sectional study of 1068 participants of the biracial Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. RESULTS: Adverse levels of most biomarkers, especially fibrinogen, factor VIII, C‐reactive protein, N‐terminal pro‐B‐type natriuretic peptide, and interleukin (IL)‐6, were associated with higher D‐dimer. Several associations with D‐dimer differed significantly by race. For example, the association of factor VIII with D‐dimer was more than twice as large in Black compared to White participants. Specifically, D‐dimer was 26% higher per standard deviation (SD) higher factor VIII in Black adults and was only 11% higher per SD higher factor VIII in White adults. In Black but not White adults, higher IL‐10 and soluble CD14 were associated with higher D‐dimer. CONCLUSIONS: Findings suggest that D‐dimer might relate to Black/White differences in cardiovascular diseases and venous thromboembolism because it is a marker of amplified thrombo‐inflammatory response in Black people. Better understanding of contributors to higher D‐dimer in the general population is needed.

• Black people have higher thrombo-inflammatory responses, reflected partly by higher D-dimer.

• We examined the associations of several thrombo-inflammatory biomarkers with D-dimer.

• We found stronger associations of some biomarkers with D-dimer in Black people.

• These responses might underlie pathways involved in health disparities impacting Black people.

Higher D-dimer, a by-product of fibrin degradation, 1 is a predictor of cardiovascular and venous thromboembolism risk in healthy people. [2] [3] [4] [5] D-dimer also appears to be the best representation in the laboratory of the summative impact of the thrombo-inflammation and risk of poor outcomes in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [6] [7] [8] [9] Several mechanisms may explain the correlation of elevated Ddimer with these diseases. D-dimer is a marker of fibrin formation; as such, elevated D-dimer reflects hypercoaguability. 10 D-dimer is also higher with inflammatory processes. 11 However, much uncertainty exists about biological mechanisms underlying the association of Ddimer and health. 12, 13 Black people have poorer cardiovascular health compared to White people, 14 and they are also at increased risk of coronavirus disease 2019 . [15] [16] [17] [18] [19] [20] Black individuals also have higher thrombo-inflammatory responses and higher D-dimer, 21 

The REGARDS study is a national, longitudinal cohort study in- For this report, existing data on multiple baseline biomarkers was leveraged from a case-cohort study of stroke and cognitive impairment risk nested within the REGARDS study. To lessen sampling bias, only the cohort random sample (1100 participants) and not those from the case groups were included in the present study.

To ensure appropriate representation by race, sex, and age categories, the random cohort was generated using a stratified sampling method. 4 Individuals taking warfarin at baseline (direct oral anticoagulants were not in use) were excluded, leaving a sample size of 1068 participants. The institutional review boards of the University Handling Editor: Pantep Angchaisuksiri 26% higher per standard deviation (SD) higher factor VIII in Black adults and was only 11% higher per SD higher factor VIII in White adults. In Black but not White adults, higher IL-10 and soluble CD14 were associated with higher D-dimer.

Conclusions: Findings suggest that D-dimer might relate to Black/White differences in cardiovascular diseases and venous thromboembolism because it is a marker of amplified thrombo-inflammatory response in Black people. Better understanding of contributors to higher D-dimer in the general population is needed.

biomarkers, cardiovascular diseases, D-dimer, race, thrombo-inflammation of Alabama at Birmingham and University of Vermont approved the study. The participants gave written informed consent. All assay analytical coefficients of variation were <5% to 10%.

Age, sex, race, income, and education were self-reported.

Hypertension was defined as systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or self-reported use of hypertensive medications. Diabetes was defined as fasting glucose ≥126 mg/dL or random plasma glucose ≥200 mg/dL or self-reported use of insulin or oral diabetes medication. Coronary heart disease (CHD) was defined as self-reported myocardial infarction or coronary surgical procedures or evidence of prior myocardial infarction on the study electrocardiogram. Body mass index (BMI) was calculated as weight (kg) divided by height (m 2 ). Statin use was determined by self-report and medication inventory conducted during the in-home examination.

The outcome of interest was D-dimer, and the following biomarkers were considered as independent variables: CRP, WBC, platelet count, albumin, NT-proBNP, IL-6, IL-8, IL-10, fibrinogen, factor VIII, and sCD14. Biomarkers that did not fit a normal distribution were natural log transformed. The mean and standard deviation (SD) or geometric mean were tabulated for all biomarkers by age groups, sex, and race.

Linear regression with Bonferroni correction was used to estimate the adjusted difference in the mean level of log-transformed D-dimer associated with a 1-SD increment of each biomarker.

Standardization of data in this manner allowed for comparison of the relative associations across biomarkers and in subgroups. Results were interpreted as the percentage difference in D-dimer per 1-SD increase in each biomarker, calculated as follows: percent difference in D-dimer = (e β -1) × 100. The 95% confidence interval (CI) of the percentage difference was obtained by replacing the β coefficient with β ± 1.96* (standard error) in the aforementioned formula.

Complete case analysis was used for all regression models. Table 1 shows that most biomarkers were higher in Black compared to White participants, including D-dimer. Albumin, WBC, NT-proBNP and sCD14 were lower in Black than White participants.

Associations of biomarkers with D-dimer are shown in Table 2 .

Biomarkers that were most strongly associated with D-dimer included fibrinogen, factor VIII, CRP, NT-proBNP, and IL-6. In the agesex-race adjusted model, D-dimer was 18% higher per SD higher fibrinogen, 20% higher per SD higher factor VIII and 21% higher per SD higher NT-proBNP. It was 23% higher per SD CRP and 24% higher per SD higher IL-6. There was an inverse association between albumin and D-dimer; D-dimer was 10% lower with each SD higher albumin. There was no confounding of these associations after adjustment for socioeconomic or clinical variables.

There were no differences in the strong associations of IL-6, CRP, or WBC with D-dimer by race, while associations of IL-10, factor VIII and sCD14 with D-dimer differed significantly by race (Table 3 , Figure 1 ). The association of factor VIII with D-dimer was more than twice as great in Black compared to White participants.

Specifically, each SD higher factor VIII was associated with a 26% greater D-dimer in Black participants, while this difference in Ddimer was only 11% in White participants (P interaction = .009). In Black participants, each SD higher IL-10 was associated with a 15% greater D-dimer, while each SD higher sCD14 was associated with a 13% greater D-dimer; these biomarkers were not associated with D-dimer in White adults (P interaction = .001 for IL-10 and .02 for sCD14). There was no confounding of these associations after adjustment for socioeconomic or clinical variables. These associations are further displayed visually in Figure 2 .

In this general population study, there was a greater basal thromboinflammatory state in Black than White individuals. Moreover, several biomarkers were more strongly associated with higher Ddimer in Black compared to White participants. These findings were not explained by the evaluated socioeconomic or clinical factors.

Findings illustrate that thrombo-inflammatory responses are greater in Black than White individuals, and this might partly explain their higher rate of cardiovascular diseases, venous thromboembolism, and COVID-19.

In accordance with these findings, in previous studies Black women had higher CRP and IL-6 than White women, and higher fibrinogen than both White and Hispanic women. [25] [26] [27] Black men and women also have higher D-dimer levels compared to their White counterparts. 25, 28 Cardiovascular markers such as NT-proBNP were also higher in Black compared to White women and men. 22 There is little known on the correlations of the studied biomarkers with D-dimer concentration, with no previous data in a general population sample. 29 Elevated factor VIII in healthy people is an established risk marker for cardiovascular disease and venous thromboembolism via effects of VWF. 33, 34 Upon vascular injury, VWF binds to the exposed subendothelial matrix that activates, adheres, and aggregates platelets via VWF. This in turn leads to thrombin generation and fibrin formation, which generates fibrin degradation products such as D-dimer. 1, 35, 36 In previous research, part of the strong association of D-dimer with future venous thromboembolism risk was explained by adjustment for factor VIII. 28 Vessel injury or endotheliopathy also play an im- Our findings similarly suggest that higher sCD14 might be part of heightened thrombo-inflammatory response in Black people, even though we observed that they have lower sCD14 levels. sCD14 is the soluble form of a pattern recognition receptor involved in innate immunity. It is induced by IL-6 and secreted by the liver. 41 Higher sCD14 level is a race-specific risk marker for future cardiovascular disease events in Black persons. 42 sCD14 level is higher in patients with pulmonary embolism, 43 These analytes were measured as participants were enrolled in an ancillary study that was funded after the first ≈8000 participants were enrolled, thus the higher number of missing.

inflammatory response induced by this virus. 44 We are not aware of data on race-specific levels in SARS-CoV-2 infection and venous thromboembolism.

Epidemiological research has not shown consistent associations of IL-10 and cardiovascular risk. Smaller studies in older adults 45 and postmenopausal women with coronary atherosclerosis 45, 46 showed that higher IL-10 correlated with increased risk of cardiovascular events. On the other hand, larger and more diverse cohort 

The authors thank the other investigators, the staff, and the partici- 

The data are not publicly available because they contain information that could compromise research participant privacy. The data that support the findings of this study are available on reasonable request from the corresponding author.

Debora Kamin Mukaz https://orcid.org/0000-0001-5573-2573

D-dimer antigen: current concepts and future prospects

D-Dimer elevation and adverse outcomes

C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies

D-dimer and the risk of stroke and coronary heart disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) study

Biomarkers and venous thromboembolism

Prevalence and outcomes of D-dimer elevation in hospitalized patients with COVID-19

Thrombosis and coagulopathy in COVID-19: an illustrated review

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome

COVID and coagulation: bleeding and thrombotic manifestations of SARS-CoV2 infection

Biochemical markers for the diagnosis of venous thromboembolism: the past, present and future

Novel aspects of fibrin(ogen) fragments during inflammation

Common genetic variants associated with plasma fibrin D-dimer concentration in older European-and African-American adults

Genetic predictors of fibrin D-dimer levels in healthy adults

Disparities in cardiovascular disease risk in the United States

Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 -COVID-NET, 14 States

Introduction to COVID-19 racial and ethnic health disparities

Hospitalization and mortality among black patients and white patients with Covid-19

Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data

Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank

Assessing differential impacts of COVID-19 on Black communities

Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers

Racial differences in cardiovascular biomarkers in the general population

The reasons for geographic and racial differences in stroke study: objectives and design

Validating laboratory results in a national observational cohort study without field centers: the reasons for geographic and racial differences in stroke cohort

Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study

Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort

Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US

Fibrin fragment D-dimer and the risk of future venous thrombosis

Factors associated with D-dimer levels in HIV-infected individuals

Impact of acute kidney injury on coagulation in adult minimal change nephropathy

D-dimer for venous thromboembolism diagnosis: 20 years later

von Willebrand factor, endothelial cell damage and atherosclerosis

The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?

Elevated factor VIII levels and risk of venous thrombosis

Markers of endothelial damage in organ dysfunction and sepsis

Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance

COVID-19: the vasculature unleashed

Endothelial cell infection and endotheliitis in COVID-19

Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research

Potential role of platelets in COVID-19: implications for thrombosis

CD14 is an acute-phase protein

Soluble CD14, ischemic stroke, and coronary heart disease risk in a prospective study: the REGARDS cohort

P-selectin and platelet-derived microparticles associated with monocyte activation markers in patients with pulmonary embolism

Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients

Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk

Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study

Interleukin-10 as a predictor of major adverse cardiovascular events in a racially and ethnically diverse population: multi-ethnic Study of Atherosclerosis

Inflammatory cytokines and ischemic stroke risk: the REGARDS cohort

The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis

In patients with idiopathic venous thrombosis, interleukin-10 is decreased and related to endothelial dysfunction

Inflammatory cytokines as risk factors for a first venous thrombosis: a prospective population-based study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The pathogenesis and treatment of the "cytokine storm" in COVID-19

COVID-19: consider cytokine storm syndromes and immunosuppression

Pro-inflammatory signaling by IL-10 and IL-22: bad habit stirred up by interferons?

Systemic racism, chronic health inequities, and COVID-19: a syndemic in the making?

Thrombo-inflammatory biomarkers and D-dimer in a biracial cohort study